News
-
-
COMMUNIQUÉ DE PRESSE
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
MedMira Inc. (TSXV:MIR) partners with Trimedic Inc. for exclusive distribution of Multiplo® TP/HIV and Reveal® G4 HIV-1/2 rapid antibody tests in Canada, aiming to improve access to rapid diagnostic testing solutions -
-
-
COMMUNIQUÉ DE PRESSE
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira receives Investigational Testing Authorizations from Health Canada for clinical trials on new applications of its Multiplo® TP/HIV rapid test, expanding testing options in Canada amid rising syphilis and HIV cases -
-
-
COMMUNIQUÉ DE PRESSE
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Inc. receives Health Canada approval for Reveal® Rapid G4 HIV-1/2 Test for POC use. Achieves 99.64% sensitivity & 99.71% specificity. Test offers immediate results for HIV detection -
-
